联动彩色成像与白光结肠镜在组织性结直肠癌筛查项目中的比较
在粪便免疫化学检测(FIT)阳性后接受筛查性结肠镜检查的连续受试者中,按1:1随机分为联动彩色成像(LCI)组或白光成像(WLI)组,两组均使用高清系统。共纳入649例受试者(LCI组326例、WLI组323例),LCI组腺瘤检出率(ADR)为51.8%,高于WLI组的43.7%(相对危险度1.19;95%CI 1.01-1.40)。作者结论为:在FIT阳性接受筛查性结肠镜检查的患者中,常规使用LCI显著提高了ADR。
要点
- LCI组ADR为51.8%,高于WLI组的43.7%(相对危险度1.19;95%CI 1.01-1.40)。
- 晚期腺瘤比例LCI组为21.2%、WLI组为18.9%,无显著差异。
- 无蒂锯齿状病变比例LCI组为8.6%、WLI组为5.9%,无显著差异。
核心结论
- 在FIT阳性接受筛查性结肠镜检查的患者中,常规使用LCI显著提高了ADR。
研究设计与样本
- 连续接受FIT阳性后筛查性结肠镜检查的受试者按1:1随机接受LCI或WLI结肠镜检查,两组均使用高清系统。
- 结肠镜检查的插入期与退镜期均使用同一指派的光源。
- 来自7个意大利中心的经验丰富内镜医师参与研究。
- 随机化按性别、年龄和筛查轮次分层。
- 主要结局指标为ADR。
主要发现
- LCI组ADR为51.8%,WLI组为43.7%(相对危险度1.19;95%CI 1.01-1.40)。
- 晚期腺瘤比例LCI组为21.2%、WLI组为18.9%;无蒂锯齿状病变比例LCI组为8.6%、WLI组为5.9%,两项比较均无显著差异。
- 多因素分析中,LCI与ADR独立相关,男性、年龄增长和肠道准备充分(波士顿肠道准备量表评分≥6)也与ADR独立相关。
- 按息肉分析,每次结肠镜检查的平均腺瘤数在LCI组与WLI组相当,而近端腺瘤的相应数值LCI组显著更高(0.72±1.2 vs 0.55±1.07,P=.05)。
关键数值与推荐
- LCI组ADR为51.8%,WLI组为43.7%;相对危险度1.19(95%CI 1.01-1.40)。
- 晚期腺瘤比例:LCI组21.2% vs WLI组18.9%(无显著差异)。
- 无蒂锯齿状病变比例:LCI组8.6% vs WLI组5.9%(无显著差异)。
- 每次结肠镜检查的平均腺瘤数:LCI组与WLI组相当。
- 近端腺瘤数:LCI组0.72±1.2 vs WLI组0.55±1.07(P=.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Linked-color imaging (LCI), a new image-enhancing technology emphasizing contrast in mucosal color, has been demonstrated to substantially reduce polyp miss rate as compared with standard white-light imaging (WLI) in tandem colonoscopy studies. Whether LCI increases adenoma detection rate (ADR) remains unclear. METHODS: Consecutive subjects undergoing screening colonoscopy after fecal immunochemical test (FIT) positivity were 1:1 randomized to undergo colonoscopy with LCI or WLI, both in high-definition systems. Insertion and withdrawal phases of each colonoscopy were carried out using the same assigned light. Experienced endoscopists from 7 Italian centers participated in the study. Randomization was stratified by gender, age, and screening round. The primary outcome measure was represented by ADR. RESULTS: Of 704 eligible subjects, 649 were included (48.9% men, mean age ± standard deviation, 60.8 ± 7.3 years) and randomized to LCI (n = 326) or WLI (n = 323) colonoscopy. The ADR was higher in the LCI group (51.8%) than in the WLI group (43.7%) (relative risk, 1.19; 95% confidence interval, 1.01-1.40). The proportions of patients with advanced adenomas and sessile serrated lesions were, respectively, 21.2% and 8.6% in the LCI arm and 18.9% and 5.9% in the WLI arm (not significant for both comparisons). At multivariate analysis, LCI was independently associated with ADR, along with male gender, increasing age, and adequate (Boston Bowel Preparation Scale score ≥6) bowel preparation. At per-polyp analysis, the mean ± standard deviation number of adenomas per colonoscopy was comparable in the LCI and WLI arms, whereas the corresponding figures for proximal adenomas was significantly higher in the LCI group (.72 ± 1.2 vs .55 ± 1.07, P = .05) CONCLUSIONS: In FIT-positive patients undergoing screening colonoscopy, the routine use of LCI significantly increased the ADR. (Clinical trial registration number: NCT03690297.).
引用
- Paggi S, Radaelli F, Senore C, et al. Linked-color imaging versus white-light colonoscopy in an organized colorectal cancer screening program. Gastrointest Endosc. 2020. PMID: 32502550. doi:10.1016/j.gie.2020.05.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。